Screener
CytomX Therapeutics CTMX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's total assets?
- CytomX Therapeutics (CTMX) reported total assets of $381.23M in Q2 2026.
- How has CytomX Therapeutics's total assets changed year-over-year?
- CytomX Therapeutics's total assets increased by 117.8% year-over-year, from $175.06M to $381.23M.
- What is the long-term trend for CytomX Therapeutics's total assets?
- Over 5 years (2020 to 2025), CytomX Therapeutics's total assets has grown at a -15.8% compound annual growth rate (CAGR), from $358.66M to $151.57M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about CytomX Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude